Merit Medical Systems Shares Outstanding 2010-2023 | MMSI
Merit Medical Systems shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
58 |
| 2022 |
58 |
| 2021 |
57 |
| 2020 |
55 |
| 2019 |
56 |
| 2018 |
54 |
| 2017 |
50 |
| 2016 |
45 |
| 2015 |
45 |
| 2014 |
43 |
| 2013 |
43 |
| 2012 |
43 |
| 2011 |
40 |
| 2010 |
36 |
| 2009 |
36 |
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-12-31 |
58 |
| 2023-09-30 |
58 |
| 2023-06-30 |
58 |
| 2023-03-31 |
58 |
| 2022-12-31 |
58 |
| 2022-09-30 |
58 |
| 2022-06-30 |
58 |
| 2022-03-31 |
58 |
| 2021-12-31 |
57 |
| 2021-09-30 |
58 |
| 2021-06-30 |
57 |
| 2021-03-31 |
57 |
| 2020-12-31 |
55 |
| 2020-09-30 |
56 |
| 2020-06-30 |
55 |
| 2020-03-31 |
55 |
| 2019-12-31 |
56 |
| 2019-09-30 |
55 |
| 2019-06-30 |
57 |
| 2019-03-31 |
56 |
| 2018-12-31 |
54 |
| 2018-09-30 |
55 |
| 2018-06-30 |
52 |
| 2018-03-31 |
52 |
| 2017-12-31 |
50 |
| 2017-09-30 |
52 |
| 2017-06-30 |
51 |
| 2017-03-31 |
46 |
| 2016-12-31 |
45 |
| 2016-09-30 |
45 |
| 2016-06-30 |
45 |
| 2016-03-31 |
45 |
| 2015-12-31 |
45 |
| 2015-09-30 |
45 |
| 2015-06-30 |
45 |
| 2015-03-31 |
44 |
| 2014-12-31 |
43 |
| 2014-09-30 |
43 |
| 2014-06-30 |
43 |
| 2014-03-31 |
43 |
| 2013-12-31 |
43 |
| 2013-09-30 |
43 |
| 2013-06-30 |
43 |
| 2013-03-31 |
43 |
| 2012-12-31 |
43 |
| 2012-09-30 |
43 |
| 2012-06-30 |
42 |
| 2012-03-31 |
42 |
| 2011-12-31 |
40 |
| 2011-09-30 |
43 |
| 2011-06-30 |
38 |
| 2011-03-31 |
36 |
| 2010-12-31 |
36 |
| 2010-09-30 |
35 |
| 2010-06-30 |
36 |
| 2010-03-31 |
36 |
| 2009-12-31 |
36 |
| 2009-09-30 |
36 |
| 2009-06-30 |
36 |
| 2009-03-31 |
36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.217B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
